Adage Capital Partners’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Adage Capital Partners’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-772,007	Closed	-$349K	–	768
2016 Q2	$349K	Hold	772,007	–	–	﹤0.01%	674
2016 Q1	$2.08M	Hold	772,007	–	–	0.01%	644
2015 Q4	$2.39M	Buy	772,007 +250,000	+48%	+$1.13M	0.01%	645
2015 Q3	$2.31M	Hold	522,007	–	–	0.01%	671
2015 Q2	$2.98M	Hold	522,007	–	–	0.01%	666
2015 Q1	$4.67M	Hold	522,007	–	–	0.01%	636
2014 Q4	$2.96M	Hold	522,007	–	–	0.01%	654
2014 Q3	$3.75M	Buy	+522,007	New	+$4.51M	0.01%	638

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Adage Capital Partners's EPRS Position: Q3 2016 in Review

Adage Capital Partners sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 772,007 shares — an estimated $349K sold.

Adage Capital Partners first reported a position in EPRS in Q3 2014 and held it in 8 quarters. The position peaked at $4.67M in Q1 2015. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

Adage Capital Partners reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Adage Capital Partners sold 772,007 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $349K.
Adage Capital Partners first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 8 quarters.
Adage Capital Partners's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $4.67M in Q1 2015.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Adage Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.